INKT
#4294
MiNK Therapeutics, Inc. - Common Stock
10.7 8 USD
0.00%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.09%
Monthly Change
-6.99%
6 month change
-2.00%
Year Change
-2.00%
Previous Close
10.7 9
Open
10.6 9
Low
10.5 8
High
10.7 8
Volume
10
Financials
- Market Capitalization 53.7 M
- Employee 15
- Founded 2017
- CEO N/A
- Website www.minktherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG012J84VS3
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.81
Price to sales ratio
264.17
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4268 |  CNTX Context Therapeutics Inc. - Common Stock | 0.62 USD | -11.43% | +1.64% | -63.10% | -4.62% | 56.97 M USD | ||
| 4280 |  BOLD Boundless Bio, Inc. - Common Stock | 2.46 USD | -1.60% | -1.60% | +69.66% | +112.07% | 55.26 M USD | ||
| 4304 |  TIL Instil Bio, Inc. - Common Stock | 7.75 USD | 0.00% | +0.65% | -4.91% | -60.24% | 52.56 M USD | ||
| 4308 |  XLO Xilio Therapeutics, Inc. - Common Stock | 9.05 USD | -2.79% | -1.42% | +18.77% | +1156.94% | 52.33 M USD |
Frequently asked questions about MiNK Therapeutics, Inc. - Common Stock
What is the MiNK Therapeutics, Inc. - Common Stock stock price today?
The current price of MiNK Therapeutics, Inc. - Common Stock (INKT) is 10.78. Over the past 24 hours, the stock has changed by -0.09%. Follow the INKT chart for real-time price dynamics.
What is the stock ticker of MiNK Therapeutics, Inc. - Common Stock?
MiNK Therapeutics, Inc. - Common Stock trades under the ticker INKT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is MiNK Therapeutics, Inc. - Common Stock stock going up?
INKT has changed by -7.78% over the last week, -6.99% over the last month, and -2.00% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was MiNK Therapeutics, Inc. - Common Stock net income for the last quarter?
MiNK Therapeutics, Inc. - Common Stock reported net income of -2.74 M for the last quarter. The previous quarter showed -2.6 M, which means net income changed by -5.39%.
How many employees does MiNK Therapeutics, Inc. - Common Stock have?
As of the latest available data, MiNK Therapeutics, Inc. - Common Stock has 15 employees. Workforce size can provide additional context about the company's scale and operations.
What is MiNK Therapeutics, Inc. - Common Stock EBITDA?
MiNK Therapeutics, Inc. - Common Stock EBITDA is -1.56 M, and its EBITDA margin is -1 930.87%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy MiNK Therapeutics, Inc. - Common Stock stock?
You can buy MiNK Therapeutics, Inc. - Common Stock (INKT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in MiNK Therapeutics, Inc. - Common Stock stock?
Investing in MiNK Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the INKT chart and related analysis on metatrader.com as part of your research.